Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2017 Nov 7;7:15260. doi: 10.1038/s41598-017-14858-z

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu 1, Mengxia Yu 1,2, Yanling Ren 1,3, Kongfei Li 4, Dominic M Maggio 5, Chen Mei 1,3, Li Ye 1,3, Juying Wei 1, Jie Jin 1, Zhengping Zhuang 5,, Hongyan Tong 1,3,
PMCID: PMC5677121  PMID: 29116110

Scientific Reports 7:2894; doi:10.1038/s41598-017-03058-4; Article published online 06 June 2017

The original version of this Article contained an error in the order of corresponding authors. This has now been corrected in the HTML and PDF versions of this Article.

Footnotes

The original article can be found online at .https://doi.org/10.1038/s41598-017-03058-4.

Contributor Information

Zhengping Zhuang, Email: ZhuangP@ninds.nih.gov.

Hongyan Tong, Email: zjuhongyantong@163.com.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES